These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 576837)

  • 41. Enhancement by prolactin of carcinogen induced mammary cancerigenesis in the male rat.
    Welsch CW; Louks G; Fox D; Brooks C
    Br J Cancer; 1975 Oct; 32(4):427-31. PubMed ID: 813753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-oestrogenic and anti-tumour properties of prolonged tamoxifen therapy in C3H/OUJ mice.
    Jordan VC; Lababidi MK; Mirecki DM
    Eur J Cancer; 1990; 26(6):718-21. PubMed ID: 2144160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of long-term treatment with norethynodrel on A-J and C3H-HeJ mice.
    Kahn RH; Baker BL
    Endocrinology; 1969 Mar; 84(3):661-8. PubMed ID: 5773162
    [No Abstract]   [Full Text] [Related]  

  • 44. Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors.
    Liao DZ; Pantazis CG; Hou X; Li SA
    Carcinogenesis; 1998 Dec; 19(12):2173-80. PubMed ID: 9886575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of diethylstilbestrol and N-nitrosobutylurea-induced mammary and pituitary tumorigenesis in rats by prolonged treatment with 2-bromoergocryptine.
    Sumi C; Yokoro K; Matsushima R
    Cancer Res; 1983 Oct; 43(10):4781-5. PubMed ID: 6883334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of cyclic progestin-estrogen therapy on sebum and acne in women.
    Strauss JS; Pochi PE
    JAMA; 1964 Nov; 190(9):815-9. PubMed ID: 12254865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
    Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
    Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of neonatal administration of norethynodrel-mestranol on the reproductive system of female mice.
    Talamantes F; Browning HC
    Tex Rep Biol Med; 1972; 30(4):361-9. PubMed ID: 4676443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
    Weikel JH; Nelson LW
    J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2-bromo-alpha-ergocryptine mesylate (CB-154) inhibits prolactin and luteinizing hormone secretion in the prepubertal female rat.
    Shaban MA; Terranova PF
    Biol Reprod; 1986 Jun; 34(5):788-95. PubMed ID: 3089338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathological changes in female C3H mice continuously fed diets containing diethylstilbestrol or 17beta--estradiol.
    Highman B; Norvell MJ; Shellenberger TE
    J Environ Pathol Toxicol; 1978; 1(1):1-30. PubMed ID: 722180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of an oral contraceptive on alpha-tocopherol levels in rat tissues.
    Aftergood L; Fields JE; Alfin-slater RB
    Nutr Rep Int; 1976 Feb; 13(2):217-24. PubMed ID: 12307790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CHOLESTATIC JAUNDICE COMPLICATING PREGNANCY: RECURRENCE AFTER NORETHYNODREL WITH ETHYNYLESTRADIOL (ENOVID).
    ELLIOTT AJ; HENDRY J
    Can Med Assoc J; 1965 Feb; 92(7):344-5. PubMed ID: 14243870
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours.
    Briand P; Thorpe SM; Daehnfeldt JL
    Br J Cancer; 1977 Jun; 35(6):816-21. PubMed ID: 577471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Some aspects of studies with oral contraceptives in Indian women.
    Shah PN
    J Obstet Gynaecol India; 1966 Aug; 16(4):409-14. PubMed ID: 12262163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of growth of carcinogen-induced mammary cancers in rats by thyrotropin-releasing hormone.
    Chen HJ; Bradley CJ; Meites J
    Cancer Res; 1977 Jan; 37(1):64-6. PubMed ID: 401473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.